Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 68788-8837

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68788-8837). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A scatter plot chart titled 'Fold Change and 90% CI' showing pharmacokinetic parameters (Cmax and AUC) for venlafaxine and its metabolite ODV in various special populations, including hepatic impairment, renal impairment, CYP2D6 metabolizer status, elderly age, and gender differences. The x-axis indicates change relative to the reference value, with dots representing fold change values for each group.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A scatter plot chart showing the fold change and 90% confidence intervals for venlafaxine and its ODV analyte with various interacting drugs. The x-axis represents the change relative to the reference value, ranging from 0 to 3. The plot compares pharmacokinetic parameters Cmax, AUC, and ODV for drugs including Ethanol, Diazepam, Cimetidine, Ketoconazole, Indinavir, Metoprolol, Imipramine, and Lithium.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A scatter plot graph showing fold change and 90% confidence intervals for various interacting drugs and analytes measured by pharmacokinetic parameters Cmax and AUC. The x-axis represents change relative to a reference value, ranging from 0 to above 3, with data points for drugs including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of venlafaxine hydrochloride showing its molecular configuration with functional groups and the hydrochloride component, labeled clearly with the compound's name below the diagram.*
FDA Label Image

Venlafaxine HCl Extended-release Capsules 75mg (Venlafaxine 37.5mg 30s.jpg)

Venlafaxine HCl Extended-release Capsules 75mg (Venlafaxine 37.5mg 30s.jpg)
Label for Venlafaxine HCl Extended-Release Capsules 75 mg, generic for Effexor ER, by Preferred Pharmaceuticals Inc. The label states each capsule contains venlafaxine hydrochloride equivalent to 75 mg venlafaxine. It includes storage instructions, manufacturer Granules India Limited, barcode, and dosage directions in English and Spanish. Lot, expiration date, and NDC fields are placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.